CHD2 p.Glu412Thr
c.1234_1235delinsAC · rs2053463440 · VCV1019442
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · substitutions only |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP 12 | GERP 2.8, phastCons 1 |
| Regional constraint | o/e 0.68 | unconstrained · MANE · 9,299 bp · p 6.4e-08 · regional, not allelic |
Population frequency
No gnomAD frequency available for this variant. This is missing data, not an absence: the variant may or may not be present in gnomAD. Rarity (ACMG PM2) and BA1/BS1 cannot be assessed for it.
Variant & gene context
- Gene
- CHD2
- Protein
- p.Glu412Thr
- Coding
- c.1234_1235delinsAC
- MANE Select
- NM_001271
- dbSNP
- rs2053463440
- Type
- Indel
- Location
- chr15:92946073 (GRCh38)
- Gene constraint
- LOEUF 0.174 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 60.81
- Residue 412
- the chromo 2 domain; a UniProt-annotated variant site (in dee94); a UniProt-annotated variant site (found in a patient with progressive myoclonus epilepsy; uncertain significance)
Disease context
developmental and epileptic encephalopathy 94 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Lennox-Gastaut syndrome (Orphanet):
- Inheritance
- Autosomal dominant, Multigenic/multifactorial, Not applicable
- Onset
- Childhood, Infancy
- Prevalence
- 1-9 / 1 000 000 (Europe)
Similar variants
- CHD2 p.Glu412Lys Uncertain significance ★ ⚠ same residue
- CHD2 c.4138-19_4138-18delinsTA Likely benign ★★ same condition
- CHD2 c.1720-155_1727delinsT Likely pathogenic ★ same condition
- CHD2 p.Ala869Phe Likely pathogenic ★ same condition
- CHD2 p.Ala929_Val934delinsTer Pathogenic ★ same condition
- CHD2 p.Glu412Ter Pathogenic ★ same residue
- CHD2 p.Leu461delinsGlnValTer Pathogenic ★ same condition
- CHD2 p.Pro155fs Pathogenic ★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/chd2-p-glu412thr (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown